Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Study reports immune and T-cell response from CanSino COVID-19 vaccine candidate. 

CanSino Vaccine Produces Immune Response

Preliminary data from a German Phase I/II trial shows Pfizer/BioNTech COVID-19 vaccine candidate produces immune response.

mRNA Vaccine Produces Immune and T-cell Response

Strong immune response by patients receiving two doses of vaccine suggests a possible treatment strategy.

AstraZeneca Vaccine Shows Antibody and T-cell responses

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Data and software identify optimum pharmaceutical packaging choices for the required shelf-life.  

Modeling Streamlines Package Stability Testing

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Demand for custom drug delivery solutions is increasing and bringing forth an exciting period of valuable, innovative development opportunities.

Demand for Custom Dosage Forms Fuels Innovation

Controlled-release formulations offer numerous advantages for developers and patients, and this market is expected to continue to experience growth in the near future.

Taking a Controlled Approach

Michael Thompson is a professor at McMaster University.

Kevin O’Donnell is R&D manager at DuPont Nutrition & Biosciences

Using a specific addition method to wet the powder bed in twin-screw granulation using a foam binder improves robustness for continuous solid-dosage drug product manufacturing.

Innovating Continuous Twin-Screw Granulation with Foam Delivery

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

Can RNA Simplify Gene Therapy Development?

EMA’s Committee for Human Medicinal Products (CHMP) has recommended that Kaftrio, a triple combination therapy for the treatment of cystic fibrosis, be authorized for marketing in the European Union. 

CHMP Recommends Marketing Authorization for Triple Combination Therapy for Cystic Fibrosis

The European Medicines Agency (EMA) has recommended a conditional marketing authorization be granted for Idefirix (imlinfidase) for the treatment of highly sensitized adult patients waiting for a kidney transplant.